Integrative transcriptome analysis identifies deregulated microRNA-transcription factor networks in lung...

Area of Science:

• Oncology
• Genomics
• Molecular Biology

Background:

• Lung adenocarcinoma is a major global health concern.
• Understanding molecular alterations, particularly microRNA (miRNA) dysregulation, is crucial for diagnosis and treatment.

Purpose of the Study:

• To identify global miRNA transcriptome changes in lung adenocarcinoma.
• To pinpoint miRNA target genes and their regulatory networks.
• To explore the prognostic value of identified miRNAs in lung cancer.

Main Methods:

• MicroRNA transcriptome sequencing and TaqMan quantitative PCR validation on training (N=24) and validation (N=34) sample sets.
• Integration of data with large-scale public datasets (1,491 lung adenocarcinoma and 455 normal lung samples).
• Bioinformatic analysis to identify differentially expressed miRNAs and construct regulatory networks.

Main Results:

• Identified 17 significantly over- and under-expressed miRNAs in lung adenocarcinoma compared to normal lung tissue.
• Validated specific miRNAs, including let-7a variants, miR-15b, miR-21, miR-155, and miR-200b.
• Found higher miR-21 expression associated with reduced patient survival (p=0.042) and identified a prognostic regulatory network involving miR-15b and miR-155.

Conclusions:

• Significant miRNA alterations are characteristic of lung adenocarcinoma.
• Specific miRNAs, such as miR-21, miR-15b, and miR-155, hold prognostic value.
• These findings may inform the development of novel therapeutic strategies for lung adenocarcinoma.